Long only, growth, momentum, contrarian

Soligenix's Most Recent Collaboration Increases Likelihood Of Clinical Success

Investments in development stage pharmaceuticals have a unique set of risks, matched with virtually unparalleled rewards for those fortunate enough, patient enough and/or educated enough to make the right decisions. Although there are many approaches to profitable investments for these potentially lucrative companies, early entry well in advance of expected catalysts can yield significant returns. While it is possible for large gains from well-known and widely-followed stocks, selections from under the radar companies can give interested investors the time to choose solid entry points without fear of having to "chase" a share price upward or having to make a quick entry before adequately completing their own due diligence. I believe I have found one such candidate possessing a unique combination...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details